Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743062 · ClinicalTrials.gov registry record · NA
Awe Inducing Elements in Virtual Reality Applications: A Prospective Study of Hospitalized Children
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT05743062: Completed NA study, sponsored by Stanford University.
NCT05743062 is a NA study that has completed, run by Stanford University. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05743062, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
This is an experimental study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers (e.g., parents, guardians)
Primary Outcome
Global Perceived Awe Survey contains an 7-point Likert scale . Scores range from 1 (strongly disagree) to 7 (Strongly agree), with higher score indicates strongly agree to the statement.
Interventions
- BEHAVIORAL Virtual Reality
- OTHER Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2023-08-03 |
| Phase | NA |
What the finished NCT05743062 record still lists
NCT05743062 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality is the first listed.
NCT05743062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05743062 about?
NCT05743062 is a clinical study titled "Awe Inducing Elements in Virtual Reality Applications: A Prospective Study of Hospitalized Children". This is an experimental study to evaluate which aspects of virtual reality (VR) software development can be optimized to increase awe in pediatric perioperative patients and their adult caregivers (e.g., parents, guardians)
What is the current status of trial NCT05743062?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2023-06-29. Estimated completion is 2023-08-03.
What interventions are being tested in trial NCT05743062?
The interventions under investigation include: Virtual Reality (BEHAVIORAL), Control (OTHER).
Who is sponsoring clinical trial NCT05743062?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05743062's enrollment target sits among peer trials
202 505th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI